Equities researchers at StockNews.com initiated coverage on shares of OpGen (NASDAQ:OPGN – Get Free Report) in a research report issued to clients and investors on Monday. The firm set a “sell” rating on the medical research company’s stock.
OpGen Price Performance
Shares of OPGN stock opened at $1.16 on Monday. OpGen has a one year low of $0.53 and a one year high of $9.90. The company’s 50-day moving average is $1.18 and its 200 day moving average is $1.82.
About OpGen
Featured Stories
- Five stocks we like better than OpGen
- Stock Average Calculator
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Dividend Payout Ratio Calculator
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- What Are Dividend Challengers?
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.